BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9261394)

  • 1. Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks.
    Kobasa D; Rodgers ME; Wells K; Kawaoka Y
    J Virol; 1997 Sep; 71(9):6706-13. PubMed ID: 9261394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.
    Suzuki T; Takahashi T; Guo CT; Hidari KI; Miyamoto D; Goto H; Kawaoka Y; Suzuki Y
    J Virol; 2005 Sep; 79(18):11705-15. PubMed ID: 16140748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses.
    Uhlendorff J; Matrosovich T; Klenk HD; Matrosovich M
    Arch Virol; 2009; 154(6):945-57. PubMed ID: 19458903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
    Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
    J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.
    Gubareva LV; Robinson MJ; Bethell RC; Webster RG
    J Virol; 1997 May; 71(5):3385-90. PubMed ID: 9094607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture.
    Baigent SJ; McCauley JW
    Virus Res; 2001 Nov; 79(1-2):177-85. PubMed ID: 11551658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine.
    Kobasa D; Wells K; Kawaoka Y
    J Virol; 2001 Dec; 75(23):11773-80. PubMed ID: 11689658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.
    Hughes MT; Matrosovich M; Rodgers ME; McGregor M; Kawaoka Y
    J Virol; 2000 Jun; 74(11):5206-12. PubMed ID: 10799596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host.
    Thompson CI; Barclay WS; Zambon MC
    J Antimicrob Chemother; 2004 May; 53(5):759-65. PubMed ID: 15028666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.
    Baigent SJ; Bethell RC; McCauley JW
    Virology; 1999 Oct; 263(2):323-38. PubMed ID: 10544106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Gubareva LV; Penn CR; Webster RG
    Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
    Leneva IA; Goloubeva O; Fenton RJ; Tisdale M; Webster RG
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1216-24. PubMed ID: 11257037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
    Gubareva LV; Webster RG; Hayden FG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.
    McKimm-Breschkin JL; Sahasrabudhe A; Blick TJ; McDonald M; Colman PM; Hart GJ; Bethell RC; Varghese JN
    J Virol; 1998 Mar; 72(3):2456-62. PubMed ID: 9499107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Goto H; Bethell RC; Kawaoka Y
    Virology; 1997 Nov; 238(2):265-72. PubMed ID: 9400599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.
    Yen HL; Herlocher LM; Hoffmann E; Matrosovich MN; Monto AS; Webster RG; Govorkova EA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4075-84. PubMed ID: 16189083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.